| Financial Year |
March 31 2023 |
| Monetary Funds |
229,510,495.45 |
| Held-for-trading Financial Assets |
98,985,097.54 |
| Notes Receivable |
1,000,000.00 |
| Accounts Receivable |
64,985,389.22 |
| Advances to Suppliers |
17,871,033.62 |
| Other Receivables |
13,703,649.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
64,346,530.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,843,586.24 |
| Total Current Assets |
504,245,781.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
203,460,963.46 |
| Investment Properties |
-- |
| Fixed Assetes |
112,387,096.23 |
| Under-construction Projects |
642,052.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,677,424.75 |
| R&D expenses |
-- |
| Goodwill |
134,532,967.47 |
| Long-Term Deferred and Prepaid Expenses |
26,694,497.50 |
| Deferred Income Tax Assets |
8,760,223.78 |
| Other Non-Current Assets |
283,018.86 |
| Sub-Total of Non-Current Assets |
574,283,214.73 |
| Total Assets |
1,078,528,996.71 |
| Short-Term Loans |
145,041,688.07 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
34,547,998.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,100,589.62 |
| Taxes Payable |
1,300,940.21 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,770,990.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,366,458.65 |
| Other Current Liabilities |
2,144,316.71 |
| Sub-Total of Current Liabilities |
223,065,836.10 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
96,274.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
26,261,720.55 |
| Total Liabilities |
249,327,556.65 |
| Paid-In Capital(Or Share Stock) |
160,047,538.00 |
| Capital Surplus |
472,057,852.06 |
| Surplus Reserve |
19,126,592.82 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
76,736,878.89 |
| Minority Stockholder's Interest |
103,239,105.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
725,962,334.08 |
| Owner's Equity（Stockholder's Equity） |
829,201,440.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,078,528,996.71 |
